The research represents a major step forward in revealing how the three dimensional form of DNA shapes the way human biology functions. In a major step toward understanding how the physical form of ...

KOLD ETF aims to provide -2x daily returns of the Bloomberg Natural Gas Sub-Index. The ETF is designed for short-term trading, not long-term holding. Investing in KOLD comes with high risk due to its ...

Redact’s new voice masking, inverse blur, and transcription features are powered by Veritone’s proprietary aiWARETM technology Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered ...

Defiance ETFs launched its newest leveraged product on Sept. 3, the Defiance Daily Target 2X Short LLY ETF (NASDAQ:LLYZ). The new fund is designed for traders seeking to short pharmaceutical giant Eli ...

Nucleoside reverse transcriptase inhibitor exposure is significantly associated with a reduced risk for subsequent development of Alzheimer Disease, reinforcing the idea that inflammasome inhibition ...

NEW YORK, June 30 (UPI) --For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse vaccines -- injections that target a specific ...

Alzheimer's disease is the most common cause of dementia and affects more than a tenth of Americans aged 65 and older. The disease has proven difficult to develop new treatments for, and available ...

Inverse ETFs offer short-term opportunities to profit from market declines in 2025, but their daily reset mechanism and high fees make them unsuitable for long-term investment. Strategic use of ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

A revolutionary treatment for autoimmune diseases could be on the horizon. Twenty-four million to 50 million Americans have an autoimmune disease, in which the body’s immune system mistakenly attacks ...

Scientists at Science Tokyo have developed an iron-based catalyst that outperforms the century-old conventional catalyst used for ammonia (NH 3) production. The team designed the catalyst with an ...